Predicting Early Hospital Readmissions in COPD Patients Using an Electronic Nose

«The major strength of our study is that it tests prospectively a novel and non-invasive diagnostic tool (e-nose) to identify hospitalized ECOPD patients at risk of early hospital readmission after discharge. However, we acknowledge that our study also has limitations. First, although sample size was formally estimated based on results previously reported by our group using the same e-nose, larger studies are needed to validate our findings. Second, we did not collect airway and blood samples from this cohort of patients to determine inflammatory markers. We plan to include these measurements in future studies using e-nose technology. Finally, we analyze our e-nose data using discriminant analyses, but we did not use gas chromatography or mass spectrometry to study the molecular correspondence of the different VOC patterns determined.
In conclusion, an electronic nose can identify hospitalized ECOPD patients at risk of early readmission after discharge».
Puedes leer el artículo completo aquí: https://www.archbronconeumol.org/en-predicting-early-hospital-readmissions-in-articulo-S0300289622000862
Autores:
Noticias relacionadas

Respiratory sequelae of preterm birth across the life span
Webinar where participants will be able to understand the role of preterm birth on long-term respiratory function and health.

COPD: Providing the right treatment for the right patient at the right time
Chronic Obstructive Pulmonary Disease (COPD) is a common disease associated with significant morbidity and mortality that is both preventable and treatable.

Vídeo de Presentación de Novedades GOLD el 23 de Noviembre de 2022 (17-19h)
Vídeo de la Presentación de las Novedades Gold 2023 del 23 de Noviembre de 2022, de 17 a 19h, presentado y moderado por El Dr. Alvar Agustí.
Más artículos
EPOC
- Alvar Agusti et Al. COPD: Providing the right treatment for the right patient at the right time
- Shyamali C Dharmage, et al. Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study.
- José Luis Izquierdo, José Miguel Rodríguez, Carlos Almonacid, María Benavent, Ramón Arroyo-Espliguero, Alvar Agustí – Real-life burden of hospitalisations due to COPD exacerbations in Spain
- Bartolome R Celli, Dave Singh, Claus Vogelmeier & Alvar Agusti. New Perspectives on Chronic Obstructive Pulmonary Disease.
- Alvar Agustí, Eleni Rapsomaniki, Richard Beasley, Rod Hughes, Hana Müllerová, Alberto Papi,Ian D. Pavord, Maarten van den Berge, Rosa Faner – Treatable traits in the NOVELTY study1. 2022
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en el artículo original el 23/01/2023.